164 related articles for article (PubMed ID: 31592859)
1. T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab: A Diagnostic Pitfall.
Santonja C; Prieto-Torres L; Pérez-Sáenz MLÁ; Requena L; Rodríguez-Pinilla SM
Am J Dermatopathol; 2020 Mar; 42(3):e36-e40. PubMed ID: 31592859
[TBL] [Abstract][Full Text] [Related]
2. Adolescent with primary cutaneous follicle center lymphoma treated with rituximab.
Devine KJ; Freiberg AS; Reilly AF
Pediatr Blood Cancer; 2024 Apr; 71(4):e30885. PubMed ID: 38253812
[No Abstract] [Full Text] [Related]
3. Primary cutaneous large B-cell lymphoma of scalp: Case report of a rare variant.
Khatib Y; Dande M; Patel RD; Makhija M
Indian J Pathol Microbiol; 2017; 60(2):268-271. PubMed ID: 28631652
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Follicle Center Lymphoma.
Skala SL; Hristov B; Hristov AC
Arch Pathol Lab Med; 2018 Nov; 142(11):1313-1321. PubMed ID: 30407851
[TBL] [Abstract][Full Text] [Related]
5. B-cell follicular lymphoma presenting as facial papules.
Valejo Coelho MM; Borges AS; Fernandes C; Ribeiro P; João A; Carvalho R
J Dtsch Dermatol Ges; 2018 Dec; 16(12):1493-1495. PubMed ID: 30417543
[No Abstract] [Full Text] [Related]
6. [What is your diagnosis? Follicular lymphoma, eliminating systemic disease but considering a diagnosis of primary cutaneous lymphoma with follicular cells].
Kamarádova K; Campr V; Kalinová M
Cesk Patol; 2012 Oct; 48(4):207-9. PubMed ID: 24044134
[No Abstract] [Full Text] [Related]
7. Follicular lymphoma presenting follicular papules in the skin: A case report.
Ozaki S; Funasaka Y; Shimizu A; Kawarasaki M; Kanzaki A; Matano Y; Futagami A; Yamaguchi H; Sugisaki Y; Saeki H
J Dermatol; 2017 Jan; 44(1):111-113. PubMed ID: 27153936
[No Abstract] [Full Text] [Related]
8. Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab.
Ferrer A; López-Guillermo A; Montoto S; Estrach T; Colomo L; Montserrat E
Ann Hematol; 2001 Aug; 80(8):479-81. PubMed ID: 11563595
[TBL] [Abstract][Full Text] [Related]
9. Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
Schmook T; Stockfleth E; Lischner S; Gahn B; Christophers E; Hauschild A
Clin Exp Dermatol; 2003 Jan; 28(1):31-3. PubMed ID: 12558625
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
[TBL] [Abstract][Full Text] [Related]
11. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous spindle cell B cell lymphoma: A report of three cases and review of the literature.
Magro CM; Momtahen S
Ann Diagn Pathol; 2017 Apr; 27():18-23. PubMed ID: 28325356
[TBL] [Abstract][Full Text] [Related]
13. Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
Lacouture ME; Baron JM; Jani AB; Laumann AE; Soltani K
Clin Exp Dermatol; 2005 Jan; 30(1):46-8. PubMed ID: 15663503
[TBL] [Abstract][Full Text] [Related]
14. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
Brunet-Possenti F; Franck N; Tamburini J; Jacobelli S; Avril MF; Dupin N
Dermatology; 2011; 223(3):200-2. PubMed ID: 21986026
[TBL] [Abstract][Full Text] [Related]
15. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
Perceau G; Diris N; Estines O; Derancourt C; Lévy S; Bernard P
Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
[TBL] [Abstract][Full Text] [Related]
16. Contribution of conventional photodynamic therapy in the treatment of primary cutaneous follicle center lymphoma.
Chaabani M; Ben Lagha I; Ben Tanfous A; Koubaa W; Ben Brahim E; Fenniche S; Zaouak A; Hammami-Ghorbel H
Int J Dermatol; 2020 Jun; 59(6):e204-e206. PubMed ID: 32043563
[No Abstract] [Full Text] [Related]
17. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous follicle center lymphomas with plasmacytic differentiation.
Skala SL; Harms PW; Fullen DR; Brown NA; Tejasvi T; Wilcox RA; Boyer DF; Hristov AC
J Cutan Pathol; 2021 May; 48(5):632-636. PubMed ID: 33184902
[TBL] [Abstract][Full Text] [Related]
19. The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
Rawal YB; Nuovo GJ; Frambach GE; Porcu P; Baiocchi RA; Magro CM
J Cutan Pathol; 2005 Oct; 32(9):616-21. PubMed ID: 16176299
[TBL] [Abstract][Full Text] [Related]
20. EUS-guided FNA diagnosis of recurrent follicular lymphoma in the transverse colon.
Fehring A; Schmulewitz N
Gastrointest Endosc; 2006 Oct; 64(4):652-3. PubMed ID: 16996367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
